Siddhesh Angle - Jun 4, 2025 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role
Director
Signature
/s/ Siddhesh Angle
Stock symbol
BBLG
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 05:01 PM
Previous filing
Sep 19, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Angle Siddhesh Rajendra Director C/O BONE BIOLOGICS CORP,, 2 BURLINGTON WOODS DR. SUITE 100, BURLINGTON, /s/ Siddhesh Angle 2025-06-06 0001889218

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBLG Non-Employee Stock Option Award $0 +62.9K $0.00 62.9K Jun 4, 2025 Common Stock 62.9K $0.88 Direct F1
holding BBLG Non-Employee Stock Option 30.7K Jun 4, 2025 Common Stock 30.7K $1.73 Direct F2
holding BBLG Non-Employee Stock Option 10.7K Jun 4, 2025 Common Stock 10.7K $5.12 Direct F3
holding BBLG Non-Employee Stock Option 154 Jun 4, 2025 Common Stock 154 $387.28 Direct F3
holding BBLG Non-Employee Stock Option 37 Jun 4, 2025 Common Stock 37 $844.80 Direct F3
holding BBLG Non-Employee Stock Option 13 Jun 4, 2025 Common Stock 13 $1,260.00 Direct F3
holding BBLG Non-Employee Stock Option 84 Jun 4, 2025 Common Stock 84 $1,260.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests in four equal quarterly installments.
F2 This option was granted on 9/17/2024 and vests in four equal quarterly installments.
F3 This option is fully exercisable as of the date of this report.